Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Drug Evaluation × Gastrointestinal × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 2 Breast 2 Plasma cell 1 Other hematologic neoplasm 1 Lymphoid 1 Gastrointestinal 1 CNS 1

Conditions

Colorectal Neoplasms 1

Interventions

Fluorouracil 554 Oxaliplatin 515 Gemcitabine 442 Capecitabine 403 Leucovorin 386 Irinotecan 349 Bevacizumab 296 Cisplatin 292 Radiotherapy 224 Cetuximab 189 Sorafenib 149 Docetaxel 135 pembrolizumab 123 Paclitaxel 123 Nivolumab 112 Albumin-Bound Paclitaxel 94 Folfox protocol 92 130-nm albumin-bound paclitaxel 89 Erlotinib Hydrochloride 88 Panitumumab 84 S 1 (combination) 78 regorafenib 74 Surgical Procedures, Operative 74 Drug Therapy 74 Radiation 61 Neoadjuvant Therapy 58 Carboplatin 56 Radiosurgery 55 Colonoscopy 54 Surveys and Questionnaires 53

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00582660 2017-06-15

UAB0040

University of Alabama at Birmingham

Phase 2 Completed

40 enrolled 7 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡